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Enhancers regulate lineage choice and the develop-
mental timing of antigen receptor gene rearrange-
ments. The transcription factor NF-
 
 
 
B has been im-
plicated as a key component of the recombination
and transcription activation potential of the immu-
noglobulin 
 
 
 
 chain gene intronic enhancer. Here, I
discuss the implications of the new observation that
an NF-
 
 
 
B binding site–mutated enhancer in the cor-
rect biological context does not appear to affect 
 
 
 
gene expression.
 
Programmed rearrangement of antigen receptor gene
loci is a hallmark of B and T lymphocyte development. Of
the two chains that make up the receptors, the Ig heavy
chain (
 
IgH
 
) and the 
 
TCR
 
 
 
 chain loci are the first to rearrange
in the B and T lineages, respectively. The production of
functional genes requires two recombination events that
juxtapose 
 
V
 
,
 
 D
 
, and 
 
J
 
 gene segments. This is followed by Ig
light chain (
 
IgL
 
) or 
 
TCR
 
 
 
 chain gene recombination,
which involves a single step that joins a 
 
V
 
 and 
 
J
 
 gene seg-
ment. The error-prone nature of the 
 
V(D)J
 
 recombinase
results in only a small proportion of pre–B or pro–T cells
generating a functional 
 
IgH
 
 or 
 
TCR
 
 
 
 gene that can express
protein. The minority of cells that express IgH or TCR
 
 
 
proteins are selected to proliferate and differentiate further
via signals from pre–B or pre–T cell receptors. Single step
recombination at the second antigen receptor locus (
 
IgL
 
 or
 
TCR
 
 
 
) and the ability to undergo sequential rearrange-
ments makes the chances of producing a functional gene at
these loci much higher. Thus, the order of gene rearrange-
ments ensures that most cells that express IgH or TCR
 
 
 
will successfully recombine 
 
IgL
 
 or 
 
TCR
 
 
 
 genes and express
a complete antigen receptor.
Developmental stage-specific recombination of antigen
receptor loci is regulated by cis-regulatory enhancer sequences
that alter accessibility of the recombinase machinery to the
gene segments. The function of enhancers is mediated by
DNA binding proteins that recruit to the enhancer, via
protein–protein interactions, a multisubunit complex that is
a functional enhancer.
 
Transcriptional Regulation of the 
 
 
 
 Locus.
 
NF-
 
 
 
B binds to
the DNA sequence known as the 
 
 
 
B site within the enhancer
(iE
 
 
 
) located in the 
 
J
 
 
 
-
 
C
 
 
 
 intron of the Ig 
 
 
 
 light chain gene
(Fig. 1 and reference 1). The presence of nuclear NF-
 
 
 
B
DNA binding activity in Ig-expressing B lymphocytes, but
not at earlier stages of B cell differentiation, suggested that
it might play a key role in 
 
 
 
 light chain gene expression.
This idea was reinforced by observations that NF-
 
 
 
B in-
duction in pre–B cell lines coordinately activates 
 
 
 
 gene
transcription and 
 
V
 
 
 
 to 
 
J
 
 
 
 recombination (2, 3). Con-
versely, both processes are adversely affected when NF-
 
 
 
B
activation is blocked (4).
In addition to 
 
 
 
B, the iE
 
 
 
 contains binding sites for several
other transcription factors (Fig. 1 A). Among these, 
 
 
 
E1-
 
 
 
E3
share a CAXXTGG sequence motif that binds proteins of
the basic helix-loop-helix (bHLH) family. 
 
 
 
E1 and 
 
 
 
E2
bind E2A proteins, whereas 
 
 
 
E3 binds TFE3 and the
closely related protein USF, which are leucine zipper
containing bHLH proteins. Functional analyses of motifs
within iE
 
 
 
 performed using isolated enhancers to activate
reporter genes in transfection assays have shown that B
cell–specific transcriptional activity of the enhancer depends
substantially on the 
 
 
 
B element (5). Moreover, iE
 
 
 
 is inac-
tive in pre–B cell lines except when the cells are treated
with LPS, an agent that activates NF-
 
 
 
B DNA binding.
Mutations of 
 
 
 
E1-
 
 
 
E3 have variable and weaker effects on
transcription compared to mutation of the 
 
 
 
B site. The 
 
 
 
B
site is also essential for the activation of recombination by
iE
 
 
 
 (6) and as an element that promotes B cell–specific
CpG demethylation of transfected genes (an epigenetic
modification that correlates with increased transcriptional
activity) (7). Cumulatively, these observations strengthened
the idea of NF-
 
 
 
B as the master and commander of 
 
 
 
 gene
expression via the 
 
 
 
B motif in iE
 
 
 
.
The past two decades have witnessed enormous growth
in the number of biological roles ascribed to NF-
 
 
 
B. First
described as a 
 
 
 
 gene–activating protein in lymphocytes, it
is now known to function in a wide variety of physiologi-
cal and pathologic processes in diverse cell types (8, 9). Per-
haps as a result, the role of the 
 
 
 
B site in the 
 
 
 
 enhancer
was somewhat neglected. In this issue, Inlay et al. perform
the definitive experiment to determine the role of the 
 
 
 
B
motif in its normal context (10). They used gene targeting
to knock in mutated iE
 
k
 
s at the endogenous locus and then
used the mutant embryonic stem cells to complement 
 
Rag
 
-
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deficient blastocysts. The status of 
 
 
 
 gene rearrangements
was compared on the wild-type and mutated alleles in ma-
ture heterozygote B cells. Surprisingly, the allele bearing
the 
 
 
 
B site mutation recombined at virtually wild-type lev-
els; in contrast, alleles bearing 
 
 
 
E1 or 
 
 
 
E2 mutations rear-
ranged less efficiently. Double mutation of the 
 
 
 
E1 and
 
 
 
E2 sites markedly reduced rearrangement to levels seen
after deletion of iE
 
 
 
 (11). The authors conclude that E2A
proteins that bind 
 
 
 
E1 and 
 
 
 
E2 are essential for efficient 
 
 
 
gene rearrangements. In contrast, the 
 
 
 
B site and NF-
 
 
 
B
appears to be unimportant for 
 
 
 
 gene recombination.
 
A Role for NF-
 
 
 
B in Epigenetic Regulation of Rearrange-
ment?
 
NF-
 
 
 
B–dependent regulation of the 
 
 
 
 locus re-
mains a viable proposition, in my opinion, because it pro-
vides a likely mechanism for the developmental timing of 
 
 
 
gene rearrangements. Though low levels have been noted
in pro–B cells, the majority of the 
 
 
 
 rearrangements occur
in the pre–B compartment after IgH-expressing cells are
selected by the pre–B cell receptor (pre-BCR). This bias
toward late rearrangements of 
 
 
 
 genes is not easily ex-
plained by an E2A-only mechanism because these bHLH
proteins are expressed in pro–B cells where they activate
 
IgH
 
 rearrangements via binding sites in the 
 
J
 
H
 
-
 
C
 
 
 
 intron
enhancer (E
 
 
 
) (12). If E2A proteins are sufficient to acti-
vate iE
 
 
 
 and are present and functional from the earliest
stages of B cell development, what prevents 
 
 
 
 genes from
recombining before the pre–B cell stage? It is possible that
E2A functions on the enhancer may be regulated differen-
tially in pro–B cells and pre–B cells. For example, increased
levels of expression or posttranslational modifications may
increase the function of E2A on iE
 
 
 
 in pre–B cells com-
pared with pro–B cells. However, there is little evidence
for such changes between pro–B and pre–B cells. Instead,
there is ample evidence for NF-
 
 
 
B activation via the pre-
BCR during the pro–B to pre–B cell transition (13, 14).
How might NF-
 
 
 
B activation render iE
 
 
 
 more suscepti-
ble to E2A-dependent activation at the correct develop-
mental stage? One possibility is that Rel proteins (the sub-
units that make up the NF-
 
 
 
B dimers) bind to the 
 
 
 
B site
in pro–B cells (15) to prevent E2A-mediated activation of
recombination (Fig. 1 B). The most likely negative regula-
tor is the p50 homodimer. This Rel protein does not con-
tain a classical activation domain and has been shown to re-
cruit histone deacetylases (HDACs) to regulatory sequences
to actively repress transcription by epigenetic means (16).
Under some circumstances, p65 (also known as RelA) be-
haves similarly (17), although it is usually associated with
gene activation. Pre-BCR–induced NF-
 
 
 
B activation in
pre–B cells may tilt the balance toward de-repression of the
 
 
 
 locus by replacing p50 homodimers with Rel proteins
that contain transcription activation domains (such as p65
or c-Rel). These Rel proteins can recruit histone acetyl
Figure 1. Regulation of the  
locus. (A) Organization of the  
light chain locus showing the J 
gene segments, intronic enhancer
(iE ), the constant region exons,
and the 3  enhancer (3 E ). The
iE  contains binding sites for
NF- B ( B), E2A ( E1,   E2),
and other transcription factors.
(B) Hypothetical model of NF-
 B–mediated repression and de-
repression of iE . Binding of p50
homodimers to the  B site at the
pro–B stage results in recruit-
ment of HDACs and inhibition
of E2A-driven transcription (top).
Replacement of p50 homodimers
by p50-p65 heterodimers at the
pro–B to pre–B cell transition
recruitsHATs which counteract
the repression and allow gene ac-
tivation by E2A proteins (bottom).Sen 1101
transferases (HATs) (18, 19) to counteract the effects of his-
tone deacetylases located on the gene, resulting in gene ac-
tivation. The crux of the hypothesis is to view the role of
NF- B at the   locus as mediating repression or de-repres-
sion depending on the stage of B cell differentiation, with
the outcome being determined by different sets of Rel pro-
teins. In this model, mutation of the  B site prevents bind-
ing of Rel proteins that initiate repression in pro–B cells, as
a result of which the timing of   gene rearrangements may
be altered. In the simplest scenario,   recombination may
occur earlier during B cell differentiation. Such NF- B–
independent recombination may be mechanistically analo-
gous to that induced by ectopic E2A expression in non-
lymphoid cells (20, 21).
If the  B site prevents E2A-dependent recombination in
pro–B cells, the  B mutant allele in the study by Inlay et al.
(10) might be expected to recombine at higher levels than
the wild-type allele because it would be accessible in both
pro–B cells and pre–B cells. However, without direct anal-
ysis of the pro–B compartment, it may be difficult to dis-
cern whether recombination is increased, given the small
numbers of pro–B cells relative to pre–B cells. Alterna-
tively, the comparable levels of recombination on both the
 B mutant and wild-type alleles in mature heterozygote B
cells (10) suggests that the  E1- plus  E2-driven enhancer
may not be effectively activated by the nuclear milieu of
the pro–B cell. What could be missing in pro–B cells that
later compensates for the loss of the  B site in pre–B cells?
One possibility is the 3   enhancer. Once activated in pre–B
cells, it may increase the recombination potential of the
“crippled”  B mutant iE , in a way serving as a surrogate
for the missing NF- B that would normally be recruited to
the locus. In the system developed by Inlay et al., this could
be tested by analyzing the effect of the  B mutation in the
absence of 3 E  (10). Clearly, however, the 3 E  cannot
rescue a  E1 plus  E2 doubly mutated iE . The proposed
insufficiency of a  B-mutated enhancer in the absence of
additional positive regulatory sequences is consistent with
all earlier functional studies of the isolated iE .
Further Implications. Epigenetic repression and de-repres-
sion via NF- B proteins provides plausible explanations
for several other aspects of   gene regulation. First, the  
locus in a minority of pro–B cells may escape p50-depen-
dent epigenetic silencing. Inefficient activation of iE  via
E2A proteins in these cells may result in the low level of  
recombination seen in pro–B cells. Second, de-repression
in pre–B cells may be limited by the concentration of
HAT-recruiting Rel family members activated by the pre-
BCR. It is possible that pre-BCR signaling is not strong
enough or does not last long enough to generate enough
positive-acting NF- B. Thus, de-repression might occur
only in that subset of cells where the level of activating Rel
proteins reaches a threshold required to counteract repres-
sion. This may be the basis for variegated   gene expression
in the pre–B compartment that was described recently by
Liang et al. (22). It is worth noting that the more uniform
expression of   genes in mature B cells probably reflects
transcription activation via the 3 E . Thus, each of the two
enhancers might serve different, though overlapping, func-
tions; iE  is primarily involved in activating V  recombina-
tion in pre–B cells, though its deficiency can be partially, or
fully, compensated depending on the severity of the muta-
tion, whereas the 3 E  is primarily involved in activating  
gene transcription. Third, the  B site–dependent epigenetic
changes proposed here must be superimposed on mono-
allelic DNA methylation of the   locus (23), a modification
that is also associated with HDAC recruitment and gene si-
lencing (24). Thus, multiple levels of epigenetic regulation
may control the timed onset of   gene recombination.
Overall, Inlay et al.’s clean experiment and its unex-
pected result proves to be more thought provoking than
anticipated. Most importantly, it demonstrates that the tim-
ing of   gene expression during B cell development re-
mains an open question, be it mediated by NF- B or by a
different, presently unknown mechanism.
I thank Drs. Yehudit Bergman and Mark Schlissel for taking the
time to share their expertise in   gene regulation during prepara-
tion of this commentary.
Submitted: 4 October 2004
Accepted: 8 October 2004
References
1. Calame, K., and R. Sen. 2003. Transcription of immuno-
globulin genes. In Molecular Biology of B Cells. T. Honjo,
F. Alt, and M. Neuberger, editors. Elsevier Science Publish-
ing Co. Inc., New York. 79–96 pp.
2. Schlissel, M.S., and D. Baltimore. 1989. Activation of immu-
noglobulin kappa gene rearrangement correlates with induc-
tion of germline kappa gene transcription. Cell. 58:1001–1007.
3. Klug, C.A., S.J. Gerety, P.C. Shah, Y.Y. Chen, N.R. Rice,
N. Rosenberg, and H. Singh. 1994. The v-abl tyrosine ki-
nase negatively regulates NF-kappa B/Rel factors and blocks
kappa gene transcription in pre-B lymphocytes. Genes Dev.
8:678–687.
4. Scherer, D.C., J.A. Brockman, H.H. Bendall, G.M. Zhang,
D.W. Ballard, and E.M. Oltz. 1996. Corepression of RelA
and c-rel inhibits immunoglobulin kappa gene transcription
and rearrangement in precursor B lymphocytes. Immunity.
5:563–574.
5. Lenardo, M., J.W. Pierce, and D. Baltimore. 1987. Protein-
binding sites in Ig gene enhancers determine transcriptional
activity and inducibility. Science. 236:1573–1577.
6. Demengeot, J., E.M. Oltz, and F.W. Alt. 1995. Promotion
of V(D)J recombinational accessibility by the intronic E kappa
element: role of the kappa B motif. Int. Immunol. 7:1995–
2003.
7. Kirillov, A., B. Kistler, R. Mostoslavsky, H. Cedar, T.
Wirth, and Y. Bergman. 1996. A role for nuclear NF-kappaB
in B-cell-specific demethylation of the Igkappa locus. Nat.
Genet. 13:435–441.
8. Amit, S., and Y. Ben-Neriah. 2003. NF-kappaB activation in
cancer: a challenge for ubiquitination- and proteasome-based
therapeutic approach. Semin. Cancer Biol. 13:15–28.
9. Smahi, A., G. Courtois, S.H. Rabia, R. Doffinger, C. Bode-
mer, A. Munnich, J.L. Casanova, and A. Israel. 2002. The
NF-kappaB signalling pathway in human diseases: from in-
continentia pigmenti to ectodermal dysplasias and immune-Commentary 1102
deficiency syndromes. Hum. Mol. Genet. 11:2371–2375.
10. Inlay, M.A., H. Tian, T. Lin, and Y. Xu. Important roles for
E protein binding sites within the immunoglobulin   chain
intronic enhancer in activating V  J  rearrangement. J. Exp.
Med. 200:1205–1211.
11. Xu, Y., L. Davidson, F.W. Alt, and D. Baltimore. 1996. De-
letion of the Ig kappa light chain intronic enhancer/matrix
attachment region impairs but does not abolish V kappa J
kappa rearrangement. Immunity. 4:377–385.
12. Kee, B.L., M.W. Quong, and C. Murre. 2000. E2A proteins:
essential regulators at multiple stages of B-cell development.
Immunol. Rev. 175:138–149.
13. Saijo, K., C. Schmedt, I.H. Su, H. Karasuyama, C.A. Lowell,
M. Reth, T. Adachi, A. Patke, A. Santana, and A. Tara-
khovsky. 2003. Essential role of Src-family protein tyrosine
kinases in NF-kappaB activation during B cell development.
Nat. Immunol. 4:274–279.
14. Tretter, T., A.E. Ross, D.I. Dordai, and S. Desiderio. 2003.
Mimicry of pre–B cell receptor signaling by activation of the
tyrosine kinase Blk. J. Exp. Med. 198:1863–1873.
15. Shaffer, A.L., A. Peng, and M.S. Schlissel. 1997. In vivo oc-
cupancy of the kappa light chain enhancers in primary pro-
and pre-B cells: a model for kappa locus activation. Immunity.
6:131–143.
16. Zhong, H., M.J. May, E. Jimi, and S. Ghosh. 2002. The
phosphorylation status of nuclear NF-kappa B determines its
association with CBP/p300 or HDAC-1. Mol. Cell. 9:625–
636.
17. Ashburner, B.P., S.D. Westerheide, and A.S. Baldwin Jr.
2001. The p65 (RelA) subunit of NF-kappaB interacts with
the histone deacetylase (HDAC) corepressors HDAC1 and
HDAC2 to negatively regulate gene expression. Mol. Cell.
Biol. 21:7065–7077.
18. Zhong, H., R.E. Voll, and S. Ghosh. 1998. Phosphorylation
of NF-kappa B p65 by PKA stimulates transcriptional activity
by promoting a novel bivalent interaction with the coactiva-
tor CBP/p300. Mol. Cell. 1:661–671.
19. Sheppard, K.A., D.W. Rose, Z.K. Haque, R. Kurokawa, E.
McInerney, S. Westin, D. Thanos, M.G. Rosenfeld, C.K.
Glass, and T. Collins. 1999. Transcriptional activation by
NF-kappaB requires multiple coactivators. Mol. Cell. Biol.
19:6367–6378.
20. Romanow, W.J., A.W. Langerak, P. Goebel, I.L. Wolvers-
Tettero, J.J. van Dongen, A.J. Feeney, and C. Murre. 2000.
E2A and EBF act in synergy with the V(D)J recombinase to
generate a diverse immunoglobulin repertoire in nonlym-
phoid cells. Mol. Cell. 5:343–353.
21. Goebel, P., N. Janney, J.R. Valenzuela, W.J. Romanow, C.
Murre, and A.J. Feeney. 2001. Localized gene-specific in-
duction of accessibility to V(D)J recombination induced by
E2A and early B cell factor in nonlymphoid cells. J. Exp.
Med. 194:645–656.
22. Liang, H.E., L.Y. Hsu, D. Cado, and M.S. Schlissel. 2004.
Variegated transcriptional activation of the immunoglobulin
kappa locus in pre-b cells contributes to the allelic exclusion
of light-chain expression. Cell. 118:19–29.
23. Mostoslavsky, R., N. Singh, A. Kirillov, R. Pelanda, H. Ce-
dar, A. Chess, and Y. Bergman. 1998. Kappa chain monoal-
lelic demethylation and the establishment of allelic exclusion.
Genes Dev. 12:1801–1811.
24. Bird, A.P., and A.P. Wolffe. 1999. Methylation-induced re-
pression–belts, braces, and chromatin. Cell. 99:451–454.